▼ -4.42% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $99.80, with a high forecast of $122.00 and a low forecast of $79.00. The average price target represents a -4.42% upside from the last price of $104.41.
The current consensus among 5 investment analysts is to hold stock in Globe Life. This rating has held steady since September 2019, when it changed from a Buy consensus rating.
Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include medicare supplement, critical illness, accident, and limited-benefit supplemental hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979 and is headquartered in McKinney, TX.